Salesforce Stock Holds Steady as UBS Keeps Target Ahead of Dreamforce
UBS has maintained its Neutral rating and $240 price target on Salesforce stock (NYSE:CRM) ahead of the company's Dreamforce conference scheduled for next week in San Francisco.
The stock currently trades at $247.80, slightly above UBS's target, though the shares have declined 6.3% over the past week.
UBS views the expanded partnership between Salesforce's CRM software suite and Anthropic's models positively, but notes it remains too early to assess how the partnership will affect Salesforce's fiscal year 2028 revenue growth profile.